Tracer library / [111In]In-DOTA-IgG

[111In]In-DOTA-IgG

Also written as [111In]In-DOTA-IgG
Radionuclide
Modality
—
Production route
—
Stage
Preclinical
Syntheses indexed
0
Gastrointestinal and colorectal cancerDosimetry and biodistribution studiesImmune cell and immunotherapy imaging

What it is

Compound class
Radiolabeled monoclonal antibody (DOTA-conjugated IgG)
Target / mechanism
CCR8 chemokine receptor PMID 41302499
Clinical application
Imaging of CCR8+ tumor-infiltrating regulatory T cells in murine colorectal cancer models to guide antibody format selection for radioimmunotherapy/immunotherapy combination PMID 41302499
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [111In]In-DOTA-IgG, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 12406626, 41302499. Stage set/updated at stage 39 from PMID 41302499: 'select the best antibody format for the pre-clinical development of this combination modality'.